Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

CTI BioPharma presents data from dose-finding PAC203 study of pacritinib

Dec. 31, 2019

Oral compound ameliorates beta-thalassemia

Dec. 30, 2019

Interim data from gene therapy trial confirm BCL11A as therapeutic target in SCD

Dec. 24, 2019

Freeline Therapeutics describes novel next-generation AAV-hFVIII vector candidate

Dec. 23, 2019

Novel mouse models of chronic sustained hypoxia and chronic intermittent hypoxia

Dec. 23, 2019

Sangamo Therapeutics presents preliminary data from phase I/II study of ST-400

Dec. 19, 2019

Hyper-sialylated IgG product M-254 well tolerated in healthy subjects in first-in-human trial

Dec. 18, 2019

Pharmacokinetic and antidrug antibody status of ABP-959 biosimilar compared to eculizumab

Dec. 17, 2019

Sanofi presents data from phase I repeat-dosing study of BIVV-001

Dec. 17, 2019

Results reported from ongoing phase I study of FT-4202

Dec. 16, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...